Duarte, Airen .
HRN: 19-19-53 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/30/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/30/2023
01/31/2023
IV
500mg
Q8 X 3 Doses
Post OP (Cesarean Section), Thickly MSAF
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: BloodstreamReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes